When confronted with cancer, Connor Christou fed everything tied tied to his regime — blood results, scan data, wearable output, journal entries — into Claude.
Many early-stage startups scale sales before they understand what they are actually commercializing. Here’s why confusing the two leads to false traction and premature scaling.
X is cutting back on payments to accounts that are “flooding the timeline” with clickbait and rapid-fire news aggregation, according to its head of product Nikita Bier